Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …

Assessing atherosclerosis severity is essential for precise patient stratification. Specifically,
there is a need to identify patients with residual inflammation because these patients remain …

Background and aims Psoriasis is an immune-mediated inflammatory disease with
increased risk of myocardial infarction. Preclinical studies in psoriasis models show an …

Psoriasis, the most common skin inflammatory disease, is characterized by massive
keratinocyte proliferation and immune cell infiltration into epidermis. L-Theanine (L-THE), a …

Background: Patients with psoriasis have increased risk of cardiovascular disease (CVD)
independent of traditional risk factors. The molecular mechanisms underlying the psoriasis …

Introduction A recent study confirmed that thiolutin (THL), as a potent inflammasome
inhibitor, plays a promising therapeutic role in multiple inflammatory disease models …

Psoriasis, a prevalent chronic inflammatory skin disorder affecting 2–3% of the global
population, has transcended its dermatological confines, revealing a profound association …

Psoriasis is an inflammatory skin disease characterized by increased neo-vascularization,
keratinocyte hyperproliferation, a pro-inflammatory cytokine milieu and immune cell …

Purpose Psoriasis is a chronic autoimmune inflammatory disease that affects skin and nails
but may also involve further sites of clinical or subclinical inflammation, including the joints …

Introduction To assess the relationship between splenic and bone marrow (BM) uptake with
the presence of large vessel vasculitis (LVV) at 18F‐FDG PET/CT and to evaluate the …